当前位置: X-MOL 学术Indian J. Ophthalmol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Assessment of the lamina cribrosa in attention-deficit hyperactivity disorder.
Indian Journal of Ophthalmology ( IF 3.1 ) Pub Date : 2021-12-01 , DOI: 10.4103/ijo.ijo_562_21
Serkan Akkaya 1 , Döndü M Ulusoy 2 , Hatice Doğan 3 , Mahmut E Arslan 2
Affiliation  

PURPOSE The aim of this study was to determine the usefulness of the lamina cribrosa thickness (LCT) and lamina cribrosa depth (LCD) in adolescence with attention-deficit hyperactivity disorder (ADHD) and compare with those receiving methylphenidate (MPH) and healthy controls. METHODS Fifty-five children with ADHD (9.23 ± 1.92 years, mean ± standard deviation), 41 children with ADHD given MPH (9.24 ± 1.84 years), and 86 healthy controls (9.95 ± 2.16 years) were recruited for the study. All subjects were subjected to a complete eye exam and optical coherence tomography (OCT) was used to assess LCT and LCD. The severity of ADHD symptoms was evaluated by using parent-report measures, including Conners's Parent Rating Scale-Revised: Short Form (CPRS-R: S) and the Strengths and Difficulties Questionnaire: Parent Form (SDQ: P). RESULTS The study showed a significant finding between the research groups with regard to LCT. LCT was shown to be significantly increased in ADHD subjects given MPH compared with the controls. However, LCD was not significantly different between cohorts. Also, a significant inverse correlation was found between the SDQ: P-Emotional Problems Subscale and LCT (r = -0.253; P = 0.030) in ADHD patients. CONCLUSION Changes in lamina cribrosa (LC) in ADHD children receiving MPH suggest that the mechanism of action for MPH may target developing LC structures. More studies to define the relationship between MPH medications and the LC variations are defensible.

中文翻译:

注意缺陷多动障碍中筛板的评估。

目的 本研究的目的是确定筛板厚度 (LCT) 和筛板深度 (LCD) 在患有注意力缺陷多动障碍 (ADHD) 的青春期的有用性,并与接受哌醋甲酯 (MPH) 和健康对照组的患者进行比较。方法 55 名 ADHD 儿童(9.23 ± 1.92 岁,平均值 ± 标准差)、41 名患有 MPH 的 ADHD 儿童(9.24 ± 1.84 岁)和 86 名健康对照(9.95 ± 2.16 岁)被招募用于研究。所有受试者都接受了完整的眼科检查,并使用光学相干断层扫描 (OCT) 来评估 LCT 和 LCD。ADHD 症状的严重程度通过使用家长报告措施进行评估,包括康纳斯家长评定量表修订版:简表 (CPRS-R: S) 和优势和困难问卷:家长表 (SDQ: P)。结果 该研究显示了研究组之间关于 LCT 的重要发现。与对照组相比,给予 MPH 的 ADHD 受试者的 LCT 显着增加。然而,LCD 在队列之间没有显着差异。此外,在 ADHD 患者的 SDQ:P 情绪问题分量表和 LCT(r = -0.253;P = 0.030)之间发现了显着的负相关。结论 接受 MPH 的 ADHD 儿童筛板 (LC) 的变化表明 MPH 的作用机制可能针对发育中的 LC 结构。更多的研究来定义 MPH 药物和 LC 变异之间的关系是合理的。LCD 在队列之间没有显着差异。此外,在 ADHD 患者的 SDQ:P 情绪问题分量表和 LCT(r = -0.253;P = 0.030)之间发现了显着的负相关。结论 接受 MPH 的 ADHD 儿童筛板 (LC) 的变化表明 MPH 的作用机制可能针对发育中的 LC 结构。更多的研究来定义 MPH 药物和 LC 变异之间的关系是合理的。LCD 在队列之间没有显着差异。此外,在 ADHD 患者的 SDQ:P 情绪问题分量表和 LCT(r = -0.253;P = 0.030)之间发现了显着的负相关。结论 接受 MPH 的 ADHD 儿童筛板 (LC) 的变化表明 MPH 的作用机制可能针对发育中的 LC 结构。更多的研究来定义 MPH 药物和 LC 变异之间的关系是合理的。
更新日期:2021-11-28
down
wechat
bug